FYERS
Home
/
Stocks
/
Results
/
Bafna Pharmaceuticals Results

Bafna Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
6%16%9%3%
-14%-1%167%
-18%43%193%
-9%10%9%12%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
BAFNAPH-BE
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,906.4₹456833 Cr37.7712.0762.82₹11479 Cr
9,155₹245426 Cr83.9134.04128.41₹2568 Cr
4,905₹187320 Cr85.8916.7297.06₹2163 Cr
1,130.6₹113217 Cr25.099.4262.53₹5040 Cr
1,377.9₹112212 Cr33.299.7757.87₹3879 Cr
1,859.8₹101155 Cr92.526.829.25₹889 Cr
2,121.4₹97626 Cr17.6630.95154.36₹5333 Cr
2,357.8₹96859 Cr47.4213.7571.08₹1913 Cr
1,158.4₹96406 Cr29.925.3263.99₹4196 Cr
1,637₹93614 Cr25.2217.9596.84₹3505 Cr
301.85₹716 Cr91.90.036.03₹11 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹27 Cr₹42 Cr₹38 Cr₹35 Cr₹35 Cr₹39 Cr₹33 Cr₹40 Cr₹33 Cr₹41 Cr₹28 Cr₹41 Cr₹42 Cr₹42 Cr₹34 Cr₹22 Cr₹17 Cr₹15 Cr₹20 Cr₹28 Cr₹21 Cr₹22 Cr₹17 Cr₹15 Cr₹17 Cr₹13 Cr₹11 Cr₹12 Cr₹7 Cr₹13 Cr₹13 Cr₹9 Cr₹12 Cr₹17 Cr₹11 Cr₹11 Cr₹9 Cr₹16 Cr₹16 Cr₹16 Cr₹21 Cr₹26 Cr₹20 Cr₹16 Cr₹23 Cr₹19 Cr₹24 Cr₹65 Cr₹35 Cr₹39 Cr₹47 Cr₹47 Cr₹45 Cr₹47 Cr₹28 Cr₹58 Cr
₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹60 L₹1 Cr₹19 L₹1 Cr₹51 L₹52 L₹98 L₹16 L₹2 Cr₹26 L₹2 Cr₹64 L₹1 Cr₹1 Cr₹49 L₹18 L₹17 L₹31 L₹4 L₹23 L₹18 L-₹67 L₹3 L₹59 L₹30 L₹31 L₹31 L-₹4 L₹9 L₹94 L₹30 Cr₹20,000₹7 L₹78 L₹78 L₹17 L₹20 L₹3 L₹22 L₹73 L₹27 L₹41 L-₹1 L₹64 L₹11 L₹37 L₹21 L-₹43 L₹1 Cr₹2 Cr₹52 L₹61 L
₹28 Cr₹44 Cr₹40 Cr₹37 Cr₹35 Cr₹40 Cr₹33 Cr₹41 Cr₹34 Cr₹42 Cr₹29 Cr₹41 Cr₹44 Cr₹43 Cr₹36 Cr₹23 Cr₹18 Cr₹16 Cr₹21 Cr₹29 Cr₹21 Cr₹22 Cr₹18 Cr₹15 Cr₹17 Cr₹12 Cr₹11 Cr₹12 Cr₹7 Cr₹13 Cr₹13 Cr₹9 Cr₹12 Cr₹17 Cr₹41 Cr₹11 Cr₹9 Cr₹17 Cr₹17 Cr₹17 Cr₹21 Cr₹26 Cr₹20 Cr₹17 Cr₹23 Cr₹19 Cr₹24 Cr₹66 Cr₹35 Cr₹40 Cr₹47 Cr₹47 Cr₹46 Cr₹48 Cr₹28 Cr₹59 Cr
₹27 Cr₹40 Cr₹37 Cr₹33 Cr₹31 Cr₹36 Cr₹32 Cr₹38 Cr₹34 Cr₹40 Cr₹32 Cr₹38 Cr₹37 Cr₹36 Cr₹33 Cr₹21 Cr₹17 Cr₹17 Cr₹19 Cr₹24 Cr₹19 Cr₹19 Cr₹16 Cr₹15 Cr₹15 Cr₹9 Cr₹12 Cr₹13 Cr₹11 Cr₹13 Cr₹13 Cr₹9 Cr₹15 Cr₹50 Cr₹11 Cr₹11 Cr₹13 Cr₹17 Cr₹17 Cr₹17 Cr₹21 Cr₹31 Cr₹19 Cr₹15 Cr₹22 Cr₹43 Cr₹26 Cr₹23 Cr₹32 Cr₹39 Cr₹42 Cr₹42 Cr₹41 Cr₹46 Cr₹24 Cr₹54 Cr
₹3 Cr₹5 Cr₹4 Cr₹5 Cr₹6 Cr₹4 Cr₹3 Cr₹5 Cr₹2 Cr₹3 Cr-₹1 Cr₹4 Cr₹8 Cr₹8 Cr₹5 Cr₹3 Cr₹3 Cr₹85 L₹3 Cr₹6 Cr₹4 Cr₹5 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹25 L₹22 L-₹3 Cr₹1 Cr₹1 Cr₹15 L-₹2 Cr-₹32 Cr₹31 Cr₹28 L-₹3 Cr₹65 L₹65 L₹36 L₹98 L-₹2 Cr₹2 Cr₹2 Cr₹2 Cr-₹23 Cr-₹86 L₹45 Cr₹6 Cr₹4 Cr₹6 Cr₹6 Cr₹6 Cr₹4 Cr₹7 Cr₹7 Cr
₹94 L₹1 Cr₹86 L₹86 L₹91 L₹82 L₹64 L₹62 L₹65 L₹68 L₹58 L₹44 L₹60 L₹70 L₹58 L₹45 L₹31 L₹21 L₹41 L₹11 L₹11 L₹38 L₹33 L₹2 L₹2 L₹3 L-₹10 L₹4 L₹13 L₹46 L₹46 L₹62 L₹83 L₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹2 Cr₹3 Cr₹2 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹8 L₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹1 Cr₹95 L₹3 Cr-₹72 L₹1 Cr-₹3 Cr₹2 Cr₹6 Cr₹6 Cr₹3 Cr₹2 Cr₹1 Cr-₹95 L₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹90 L₹48 L₹2 Cr₹1 Cr-₹22 Cr-₹55 L-₹4 Cr₹12 L₹12 L-₹1 Cr-₹4 Cr-₹34 Cr₹28 Cr-₹3 Cr-₹6 Cr-₹3 Cr-₹3 Cr-₹4 Cr-₹3 Cr-₹8 Cr-₹2 Cr-₹2 Cr-₹1 Cr-₹26 Cr-₹5 Cr₹36 Cr₹42 L-₹3 Cr₹2 Cr₹2 Cr₹2 Cr-₹1 Cr₹2 Cr₹3 Cr
₹8 L₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹1 Cr₹95 L₹3 Cr-₹72 L₹1 Cr-₹3 Cr₹2 Cr₹6 Cr₹5 Cr₹3 Cr₹2 Cr₹1 Cr-₹95 L₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹90 L₹48 L₹2 Cr-₹16 L-₹22 Cr-₹59 L-₹2 Cr₹6 L₹6 L-₹1 Cr-₹4 Cr-₹34 Cr₹28 Cr-₹3 Cr-₹8 Cr-₹3 Cr-₹3 Cr-₹4 Cr-₹3 Cr-₹7 Cr-₹2 Cr-₹2 Cr-₹1 Cr-₹23 Cr-₹5 Cr₹33 Cr₹31 L-₹2 Cr₹1 Cr₹1 Cr₹1 Cr-₹66 L₹1 Cr₹2 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
———————————————————
₹24 Cr₹24 Cr₹24 Cr₹24 Cr₹24 Cr₹24 Cr₹2 Cr₹24 Cr₹24 Cr₹19 Cr₹19 Cr₹19 Cr₹19 Cr₹19 Cr₹18 Cr₹17 Cr₹16 Cr₹16 Cr₹10 Cr
₹0₹0₹0₹0₹0₹0₹55 Cr₹0₹0₹4 Cr₹0₹0₹0₹3 Cr₹6 Cr₹3 Cr₹0₹0₹0
₹72 Cr₹61 Cr₹57 Cr₹50 Cr₹38 Cr₹33 Cr-₹7 Cr-₹3 Cr₹17 Cr₹22 Cr₹41 Cr₹53 Cr₹50 Cr₹46 Cr₹40 Cr₹34 Cr₹25 Cr₹23 Cr₹2 Cr
₹72 Cr₹61 Cr₹57 Cr₹50 Cr₹38 Cr₹33 Cr-₹7 Cr-₹3 Cr₹17 Cr₹22 Cr₹41 Cr₹53 Cr₹50 Cr₹46 Cr₹40 Cr₹34 Cr₹25 Cr₹23 Cr₹2 Cr
₹96 Cr₹85 Cr₹81 Cr₹73 Cr₹62 Cr₹57 Cr₹51 Cr₹21 Cr₹41 Cr₹45 Cr₹59 Cr₹72 Cr₹69 Cr₹67 Cr₹64 Cr₹54 Cr₹41 Cr₹39 Cr₹12 Cr
₹16 Cr₹13 Cr₹9 Cr₹7 Cr₹3 Cr₹3 Cr₹0₹21 Cr₹21 Cr₹37 Cr₹35 Cr₹10 Cr₹20 Cr₹23 Cr₹24 Cr₹31 Cr₹30 Cr₹23 Cr₹23 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹4 L₹1 Cr₹2 Cr
₹0₹0₹0₹0₹0₹0₹0₹6 Cr₹5 Cr₹3 Cr₹3 Cr₹4 Cr₹6 Cr₹5 Cr₹5 Cr₹3 Cr₹2 Cr₹1 Cr₹12 L
₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹85 L₹3 Cr₹0₹3 L₹3 L₹3 L₹3 L₹3 L₹93 L₹88 L₹61 L₹0₹0₹0₹0
₹42 L₹48 L₹39 L₹0₹0₹10 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹22 Cr₹16 Cr₹13 Cr₹10 Cr₹6 Cr₹5 Cr₹3 Cr₹29 Cr₹28 Cr₹42 Cr₹39 Cr₹14 Cr₹27 Cr₹29 Cr₹29 Cr₹34 Cr₹32 Cr₹25 Cr₹25 Cr
———————————————————
₹31 Cr₹31 Cr₹35 Cr₹28 Cr₹12 Cr₹11 Cr₹13 Cr₹39 Cr₹28 Cr₹23 Cr₹30 Cr₹35 Cr₹39 Cr₹72 Cr₹53 Cr₹25 Cr₹10 Cr₹13 Cr₹13 Cr
₹13 Cr₹11 Cr₹7 Cr₹5 Cr₹3 Cr₹4 Cr₹5 Cr₹8 Cr₹8 Cr₹14 Cr₹12 Cr₹12 Cr₹8 Cr₹6 Cr₹4 Cr₹2 Cr₹77 L₹90 L₹1 Cr
₹12 Cr₹9 Cr₹10 Cr₹12 Cr₹5 Cr₹10 Cr₹0₹23 Cr₹23 Cr₹43 Cr₹45 Cr₹53 Cr₹79 Cr₹68 Cr₹57 Cr₹20 Cr₹0₹0₹0
₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹50 L₹30 L₹19 L
₹57 Cr₹52 Cr₹54 Cr₹46 Cr₹22 Cr₹24 Cr₹17 Cr₹71 Cr₹59 Cr₹81 Cr₹87 Cr₹100 Cr₹126 Cr₹147 Cr₹114 Cr₹48 Cr₹11 Cr₹14 Cr₹14 Cr
₹176 Cr₹153 Cr₹148 Cr₹130 Cr₹90 Cr₹86 Cr₹71 Cr₹121 Cr₹128 Cr₹167 Cr₹185 Cr₹185 Cr₹223 Cr₹243 Cr₹207 Cr₹136 Cr₹84 Cr₹78 Cr₹51 Cr
₹20 Cr₹17 Cr₹18 Cr₹10 Cr₹6 Cr₹2 Cr₹5 Cr₹3 L₹46 L₹29 L₹3 Cr₹12 Cr₹18 Cr₹14 Cr₹14 Cr₹12 Cr₹7 Cr₹6 Cr₹5 Cr
₹37 Cr₹28 Cr₹24 Cr₹23 Cr₹11 Cr₹13 Cr₹3 Cr₹46 Cr₹47 Cr₹82 Cr₹80 Cr₹64 Cr₹99 Cr₹91 Cr₹81 Cr₹51 Cr₹30 Cr₹24 Cr₹25 Cr
———————————————————
₹134 Cr₹106 Cr₹99 Cr₹95 Cr₹88 Cr₹80 Cr₹74 Cr₹73 Cr₹73 Cr₹72 Cr₹72 Cr₹70 Cr₹85 Cr₹83 Cr₹82 Cr₹41 Cr₹37 Cr₹37 Cr₹4 Cr
₹52 Cr₹47 Cr₹59 Cr₹54 Cr₹49 Cr₹44 Cr₹39 Cr₹36 Cr₹33 Cr₹29 Cr₹25 Cr₹22 Cr₹22 Cr₹17 Cr₹12 Cr₹7 Cr₹5 Cr₹3 Cr₹2 Cr
₹82 Cr₹59 Cr₹40 Cr₹40 Cr₹39 Cr₹36 Cr₹35 Cr₹37 Cr₹40 Cr₹43 Cr₹47 Cr₹49 Cr₹63 Cr₹66 Cr₹70 Cr₹33 Cr₹32 Cr₹34 Cr₹2 Cr
₹3 Cr₹7 Cr₹10 Cr₹0₹0₹83 L₹21 L₹0₹0₹0₹0₹0₹0₹0₹0₹14 Cr₹6 Cr₹3 Cr₹21 Cr
₹5,000₹5,000₹0₹0₹0₹0₹0₹1 Cr₹1 Cr₹18 Cr₹18 Cr₹18 Cr₹1 Cr₹1 Cr₹1 Cr₹0₹0₹0₹0
₹5,000₹5,000₹0₹0₹0₹0₹0₹1 Cr₹1 Cr₹18 Cr₹18 Cr₹18 Cr₹1 Cr₹1 Cr₹1 Cr₹0₹0₹0₹0
₹96 L₹81 L₹73 L₹54 L₹42 L₹0₹0₹33 Cr₹37 Cr₹28 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹70 L₹0₹0₹0₹0₹100 L₹53 L₹58 L₹0₹86 L₹1 Cr₹2 Cr₹96 L₹21 L₹0₹0₹0
₹86 Cr₹67 Cr₹54 Cr₹42 Cr₹39 Cr₹37 Cr₹35 Cr₹72 Cr₹79 Cr₹90 Cr₹65 Cr₹68 Cr₹66 Cr₹69 Cr₹72 Cr₹47 Cr₹39 Cr₹37 Cr₹32 Cr
———————————————————
₹29 Cr₹28 Cr₹30 Cr₹22 Cr₹20 Cr₹15 Cr₹11 Cr₹9 Cr₹11 Cr₹17 Cr₹16 Cr₹15 Cr₹27 Cr₹21 Cr₹23 Cr₹15 Cr₹9 Cr₹5 Cr₹5 Cr
₹44 Cr₹40 Cr₹45 Cr₹41 Cr₹15 Cr₹10 Cr₹6 Cr₹25 Cr₹24 Cr₹54 Cr₹68 Cr₹83 Cr₹93 Cr₹85 Cr₹82 Cr₹35 Cr₹20 Cr₹24 Cr₹10 Cr
₹2 Cr₹3 Cr₹1 Cr₹8 Cr₹17 L₹2 Cr₹8 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹21 Cr₹2 Cr₹12 Cr₹2 Cr₹2 Cr₹1 Cr
₹2 Cr₹62 L₹57 L₹37 L₹27 L₹12 Cr₹7 Cr₹6 Cr₹5 Cr₹3 Cr₹2 Cr₹1 Cr₹4 Cr₹4 Cr₹3 Cr₹1 Cr₹79 L₹61 L₹40 L
₹13 Cr₹12 Cr₹17 Cr₹16 Cr₹15 Cr₹11 Cr₹3 Cr₹5 Cr₹6 Cr₹86 L₹30 Cr₹15 Cr₹22 Cr₹36 Cr₹22 Cr₹25 Cr₹12 Cr₹7 Cr₹2 Cr
₹90 Cr₹85 Cr₹94 Cr₹87 Cr₹51 Cr₹50 Cr₹36 Cr₹48 Cr₹48 Cr₹77 Cr₹119 Cr₹117 Cr₹149 Cr₹167 Cr₹132 Cr₹87 Cr₹44 Cr₹39 Cr₹19 Cr
₹32 Cr₹33 Cr₹40 Cr₹41 Cr₹29 Cr₹25 Cr₹19 Cr-₹22 Cr-₹11 Cr-₹4 Cr₹32 Cr₹18 Cr₹23 Cr₹21 Cr₹18 Cr₹40 Cr₹33 Cr₹25 Cr₹4 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹72 L₹0₹8 Cr₹6 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹26 L
₹176 Cr₹153 Cr₹148 Cr₹130 Cr₹90 Cr₹86 Cr₹71 Cr₹121 Cr₹128 Cr₹167 Cr₹185 Cr₹185 Cr₹223 Cr₹243 Cr₹207 Cr₹136 Cr₹84 Cr₹78 Cr₹51 Cr
₹41₹36₹34₹31₹26₹24-₹19₹9₹17₹22₹31₹38₹33₹31₹30₹29₹25₹23₹12
₹41₹36₹34₹31₹26₹24-₹19₹9₹17₹22₹31₹38₹33₹31₹30₹29₹25₹23₹12

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
₹11 Cr₹4 Cr₹7 Cr₹12 Cr₹5 Cr₹6 Cr-₹2 Cr-₹18 Cr-₹14 Cr-₹19 Cr-₹13 Cr₹6 Cr₹2 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹2 Cr₹1 Cr
₹10 Cr₹10 Cr₹8 Cr₹8 Cr₹6 Cr₹4 Cr-₹20 Cr₹5 Cr-₹20 Cr₹15 Cr₹15 Cr-₹25 Cr₹19 Cr₹16 Cr₹10 Cr₹7 Cr₹4 Cr₹3 Cr₹88 L
-₹6 Cr₹8 Cr-₹5 Cr-₹14 Cr-₹80 L-₹23 Cr-₹12 Cr₹12 Cr₹27 Cr₹24 Cr-₹6 Cr₹30 Cr-₹20 Cr₹15 Cr₹13 Cr-₹17 Cr-₹8 Cr-₹19 Cr-₹4 Cr
₹15 Cr₹22 Cr₹10 Cr₹5 Cr₹10 Cr-₹14 Cr-₹34 Cr-₹1 Cr-₹7 Cr₹20 Cr-₹3 Cr₹12 Cr₹1 Cr₹36 Cr₹29 Cr-₹6 Cr-₹9 L-₹14 Cr-₹2 Cr
₹15 Cr₹22 Cr₹9 Cr₹5 Cr₹10 Cr-₹14 Cr-₹34 Cr-₹1 Cr-₹7 Cr₹20 Cr-₹3 Cr₹9 Cr₹77 L₹35 Cr₹28 Cr-₹6 Cr-₹59 L-₹14 Cr-₹2 Cr
-₹22 Cr-₹21 Cr-₹15 Cr-₹7 Cr-₹7 Cr-₹5 Cr₹33 Cr₹4 Cr₹38 Cr-₹14 Cr-₹1 Cr₹56 Cr-₹5 Cr-₹6 Cr-₹37 Cr-₹11 Cr-₹3 Cr-₹6 Cr-₹7 Cr
₹6 Cr₹1 Cr-₹85 L₹10 Cr-₹5 Cr₹12 Cr₹7 Cr-₹2 Cr-₹31 Cr-₹5 Cr₹4 Cr-₹66 Cr-₹14 Cr-₹11 Cr-₹51 L₹27 Cr₹4 Cr₹20 Cr₹8 Cr
-₹1 Cr₹2 Cr-₹6 Cr₹8 Cr-₹2 Cr-₹7 Cr₹6 Cr-₹21,000₹5 L-₹4 L₹25 L-₹2 L-₹18 Cr₹18 Cr-₹9 Cr₹10 Cr-₹19 L₹84 L-₹58 L
₹3 Cr₹1 Cr₹8 Cr₹17 L₹2 Cr₹8 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹21 Cr₹2 Cr₹12 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr
₹2 Cr₹3 Cr₹1 Cr₹8 Cr₹17 L₹2 Cr₹8 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹21 Cr₹2 Cr₹12 Cr₹2 Cr₹2 Cr₹1 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)296.00
Volume (₹)3,458.00
High (₹)296.60
Upper Circuit307.85
Low (₹)296.00
Lower Circuit295.85
Prev Close301.85
52W High (₹)318.50
Price296.00
52W Low (₹)94.77

Share Market Cap & Key Ratios Overview

M.Cap (₹)715.72 Cr
Div. Yield (%)0.00
PE Ratio91.90
Debt to Equity0.39
Price to Book2.78
Book Value40.64
EPS (TTM)3.29
Face Value10.00
ROE (%)12.27

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
BAFNAPH-BENSE
LTP
1W Low
1W High
Market cap (₹)
1903.2-16.8 (-0.87%)
1900.10
1984.80
4,56,833Cr
9159.5-79.5 (-0.86%)
9087
9467
2,45,426Cr
4844.5-205.5 (-4.07%)
4844.50
5066
1,87,320Cr
1131.4-59.6 (-5.00%)
1125.10
1187
1,13,217Cr
1378.2-45.3 (-3.18%)
1376.70
1426.10
1,12,212Cr
1843-95.5 (-4.93%)
1811.70
1949
1,01,155Cr
2112.6-58.9 (-2.71%)
2111.10
2192
97,626Cr
2337.6-45.3 (-1.90%)
2335
2419.20
96,859Cr
1161.4-16.6 (-1.41%)
1154.40
1179.90
96,406Cr
1656.1+10.8 (0.66%)
1622.60
1717
93,614Cr
296+4.9 (1.68%)
291
318.50
716Cr

Bafna Pharmaceuticals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹3.57Cr; with other income of ₹-₹67.1Lakh, profit before interest and tax came to ₹2.21Cr. Interest expense was ₹2.5Lakh; PBT before exceptional items stood at ₹2.18Cr. Cost mix (full year): raw materials ₹19.41Cr; employee cost ₹10.25Cr; depreciation ₹52.5Lakh; other expenses ₹8.89Cr. Basis: consolidated annual results.

Bafna Pharmaceuticals Ltd Quaterly Results Key Takeaways

Bafna Pharmaceuticals Ltd reported ₹13.13Cr total income from operations in Mar 2020, softer than ₹10.93Cr in Dec 2019 but higher than ₹13.07Cr in Dec 2018. Operating profit (before other income, interest and exceptional items) was ₹3.57Cr; with other income of ₹-₹67.1Lakh, profit before interest and tax came to ₹2.21Cr. Interest expense was ₹2.5Lakh, taking profit before tax to ₹2.18Cr. After tax of ₹1.58Cr, profit after tax stood at ₹60.5Lakh (vs ₹-₹22.33Cr in Dec 2019 and ₹6.3Lakh in Dec 2018).